Abbott Laboratories engages in the discovery ... The Medical Devices segment includes electrophysiology, heart failure, vascular and structural heart devices for the treatment of cardiovascular ...

Cagent Vascular, Inc., the exclusive developer of serration technology for vessel dilation in endovascular interventions, ...

and Abbott (NYSE: ABT). With a proven track record of driving revenue growth, expanding market share, and fostering strategic partnerships, he will play a critical role in scaling Cagent Vascular ...